Educational Videos for Thyroid Surgery Patient
Patient Education on Postoperative TSH Suppression Therapy for Differentiated Thyroid Cancer Using Science Popularization Videos: A Prospective, Multicenter, Randomized Controlled Trial
1 other identifier
interventional
400
0 countries
N/A
Brief Summary
The researchers aim to evaluate the performance of two groups of participants after receiving traditional education-one group supplemented with video-based education and the other without. This study will explore the feasibility of using guideline-based public education videos on postoperative TSH suppression therapy for differentiated thyroid cancer in the context of public education regarding thyroid surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 14, 2025
CompletedFirst Posted
Study publicly available on registry
September 16, 2026
CompletedStudy Start
First participant enrolled
October 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
September 16, 2026
September 1, 2026
1.2 years
December 14, 2025
September 12, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
TSH Compliance Rate
The criteria for determining the TSH target achievement rate are based on a combination of three factors: the patient's postoperative recurrence risk stratification, the follow-up time point, and the current TSH test result. Within one year postoperatively, the TSH suppression targets are \< 0.1 mU/L for the high-risk group, 0.1-0.5 mU/L for the moderate-risk group, and 0.1-0.5 mU/L (low Tg) or 0.5-2 mU/L (undetectable Tg, lobectomy) for the low-risk group. In statistical analysis, the TSH target range attainment rate = (number of patients with TSH levels within the target range at each follow-up time point / total number of patients followed up at that time point) × 100%
Postoperative Month 1, Postoperative Month 3, Postoperative Month 6, and Postoperative Month 12
Patient satisfaction
Patient satisfaction following different educational approaches was assessed using a 5-point Likert scale (1-5 scale; the higher the score, the higher the satisfaction).
Immediately after the educational presentation (post-intervention)
Secondary Outcomes (4)
Level of knowledge dissemination
Postoperative Month 1, Postoperative Month 3, Postoperative Month 6, and Postoperative Month 12
Patient anxiety level
Baseline (before the educational outreach) and immediately after the educational outreach; two assessments total
Patient's Level of Regret After Surgery
Baseline (before the educational outreach) and immediately after the educational outreach
Incidence of adverse events in patients
Postoperative Month 1, Postoperative Month 3, and Postoperative Month 6
Study Arms (2)
Intervention group
EXPERIMENTALAccepting educational video on postoperative TSH suppression therapy for differentiated thyroid cancer produced by researchers in accordance with guidelines
Non-intervention group
NO INTERVENTIONWithout any additional intervention
Interventions
Accepting educational video on postoperative TSH suppression therapy for differentiated thyroid cancer created by researchers based on guidelines
Eligibility Criteria
You may qualify if:
- Patients scheduled for thyroid surgery, aged between 18 and 60 years old
You may not qualify if:
- Unable to read and write, pregnant, or with a history of thyroid surgery;
- suffering from other malignant tumors or mental disorders;
- unable to complete the questionnaire independently or requiring assistance from others.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 14, 2025
First Posted
September 16, 2026
Study Start
October 1, 2026
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
September 16, 2026
Record last verified: 2026-09